cysteamine November 30, 2017[email protected] cysteamine Trade Name Orphan Indication Neuronal ceroid lipofuscinoses (Batten disease) USA Market Approval USA USA Designation Date 2008-08-06 00:00:00 Sponsor Raptor Pharmaceuticals, Inc.;9 Commercial Blvd., Suite 200;Novato, California, 94949
